Nalaganje...
An overview of antibody–drug conjugates in oncological practice
Antibody–drug conjugates (ADCs) are designed to manipulate the toxic efficacy of specific chemotherapeutic compounds, employing the high affinity of antibody-mediated delivery so as to drive them selectively to target cancer cells. These immunoconjugates encompass the general tendency towards precis...
Shranjeno v:
| izdano v: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7543133/ https://ncbi.nlm.nih.gov/pubmed/33088347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920962997 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|